{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:36:58Z","timestamp":1790318218984,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DRDO-DFRL"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.imlet.2017.10.013","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T12:39:37Z","timestamp":1509021577000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-\u03b3 and IL-12p70 protective immune response in BALB\/c mice against virulent Brucella"],"prefix":"10.1016","volume":"192","author":[{"given":"Ganesh","family":"Tadepalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balakrishna","family":"Konduru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harishchandra Sripathy","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh Vardhan","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.10.013_bib0005","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/JB.01091-13","article-title":"Comparative phylogenomics and evolution of the brucellae reveal a path to virulence","volume":"196","author":"Wattam","year":"2014","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.imlet.2017.10.013_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.01337-14","article-title":"Recovery of a medieval Brucella melitensis genome using shotgun metagenomics","volume":"5","author":"Kay","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.imlet.2017.10.013_bib0015","first-page":"1","article-title":"Decreased in vivo virulence and altered gene expression by a Brucella melitensis light-sensing histidine kinase mutant","volume":"73","author":"Gourley","year":"2014","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.imlet.2017.10.013_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2016.05.011","article-title":"Activation of bovine neutrophils by Brucella spp","volume":"177","author":"Keleher","year":"2016","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.imlet.2017.10.013_bib0025","first-page":"55","article-title":"Brucellosis: review on the recent trends in pathogenecity and laboratory diagnosis","volume":"22","author":"Sardana","year":"2010","journal-title":"J. Lab. Phys."},{"key":"10.1016\/j.imlet.2017.10.013_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2012.00002","article-title":"Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics","volume":"2","author":"He","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.imlet.2017.10.013_bib0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cimid.2016.01.006","article-title":"An evaluation of ELISA using recombinant Brucella abortus bacterioferritin (Bfr) for bovine brucellosis","volume":"45","author":"Hop","year":"2016","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.imlet.2017.10.013_bib0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.micpath.2016.04.009","article-title":"Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB\/c mice","volume":"95","author":"Truong","year":"2016","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.imlet.2017.10.013_bib0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2014.06.017","article-title":"Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in Mice","volume":"62","author":"Ghasemi","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2017.10.013_bib0050","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.vaccine.2015.12.028","article-title":"Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection","volume":"34","author":"Tabynov","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.10.013_bib0055","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/j.vaccine.2014.09.013","article-title":"Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection","volume":"32","author":"Ghasemi","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.10.013_bib0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molimm.2015.04.015","article-title":"Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7\/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen","volume":"66","author":"Golshani","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2017.10.013_bib0065","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.vaccine.2015.09.013","article-title":"Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection","volume":"33","author":"Ghasemi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.10.013_bib0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.molimm.2016.01.001","article-title":"Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model","volume":"71","author":"Tadepalli","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2017.10.013_bib0075","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2007.03.028","article-title":"A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination","volume":"25","author":"Cassataro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.10.013_bib0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front. Biol. (Beijing)"},{"key":"10.1016\/j.imlet.2017.10.013_bib0085","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.10.013_bib0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molimm.2014.01.012","article-title":"Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model","volume":"59","author":"Makam","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2017.10.013_bib0095","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.vaccine.2014.03.021","article-title":"Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein","volume":"32","author":"Uppalapati","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.10.013_bib0100","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1016\/j.vaccine.2015.07.011","article-title":"Immunogenicity of porcine P[6], P[7]-specific VP8 rotavirus subunit vaccines with a tetanus toxoid universal T cell epitope","volume":"33","author":"Wen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.10.013_bib0105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molimm.2015.09.011","article-title":"PLGA (85:15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: a promising alternate to traditional adjuvants","volume":"68","author":"Singh","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2017.10.013_bib0110","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1016\/j.vaccine.2014.07.106","article-title":"Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis","volume":"32","author":"Vrushabhendrappa","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.10.013_bib0115","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect. Immun."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781730295X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781730295X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T09:39:25Z","timestamp":1535276365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524781730295X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":23,"alternative-id":["S016524781730295X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.10.013","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-\u03b3 and IL-12p70 protective immune response in BALB\/c mice against virulent Brucella","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}